₹1.44 crore today (31st October, 2020). While the same invested in Nifty would have become about ₹1.32 crore and in Nifty Pharma about ₹96 lakh during the same period.
Kotak Mahindra Portfolio Management Service division (Kotak PMS), ahead of Diwali announced that it will share profits with investors generated from the Kotak Pharma and Healthcare (Kotak Pharma) portfolio.
Pharma and healthcare stocks have become market darlings. This has been driven by market expectations of a likely shift in global Pharma supply chains away from China and toward India.
Kotak Pharma and healthcare portfolio has been a direct beneficiary of this trend.Kotak Pharma & Healthcare portfolio has registered 13% returns over the past three years as compared to 4.8%.
Read more on livemint.com